Prime Medicine (PRME) Total Current Liabilities (2021 - 2026)

Prime Medicine (PRME) has 6 years of Total Current Liabilities data on file, last reported at $36.3 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities rose 5.84% year-over-year to $36.3 million; the trailing twelve-month figure through Mar 2026 stood at $36.3 million (up 5.84% YoY), and the FY2025 full-year result was $37.4 million, down 1.35% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $36.3 million, down from $37.4 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $56.4 million in Q4 2023 and bottomed at $20.7 million in Q2 2024.
• The 5-year median for Total Current Liabilities is $34.3 million (2025), against an average of $33.0 million.
• The widest annual swing landed in 2022, when Total Current Liabilities tumbled 53.93%; it then jumped 111.21% in 2023.
• A 5-year view of Total Current Liabilities shows it stood at $26.7 million in 2022, then surged by 111.21% to $56.4 million in 2023, then sank by 32.72% to $38.0 million in 2024, then decreased by 1.35% to $37.4 million in 2025, then retreated by 3.09% to $36.3 million in 2026.
• The last three Total Current Liabilities figures came in at $36.3 million (Q1 2026), $37.4 million (Q4 2025), and $35.0 million (Q3 2025), per Business Quant data.

Peer Comparison